Sminu Bose

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Placebo Controlled

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Karan Luthria, Parin Shah, Blake Caldwell, Johannes C Melms, Sinan Abuzaid, Viktoria Jakubikova, D Zack Brodtman, Sminu Bose, Amit Dipak Amin, Patricia Ho, Jana Biermann, Somnath Tagore, Matthew A Ingham, Gary K Schwartz, Benjamin Izar
Single-cell profiling of sarcomas from archival tissue reveals programs associated with resistance to immune checkpoint blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Matthew A Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose S Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A Burgess, Mahesh Seetharam, Sosipatros A Boikos, Nam Q Bui, James L Chen, Julia L Close, Gregory M Cote, Premal H Thaker, Susan Percy Ivy, Sminu Bose, Alan D' Andrea, Adrian Mariño-Enriquez, Geoffrey I Shapiro, Gary K Schwartz
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sminu Bose, Tristan Y Lee, Shaelyn Choi, Ladan Fazlollahi, Michael J Rasiej, Gary K Schwartz, Matthew A Ingham
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone. JCO precision oncology 6 (2022)